Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Provecta: Completed Phase II enrollment

Provectus completed enrollment of 80 patients in an open-label, international

Read the full 103 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE